Department of Pediatrics, Division of Pulmonary Medicine, University of Michigan Medical School, Ann Arbor, MI, United States.
Department of Surgery, University of Michigan Medical School, Ann Arbor, MI, United States.
Mol Metab. 2020 Sep;39:100983. doi: 10.1016/j.molmet.2020.100983. Epub 2020 Mar 27.
Expansion of visceral adipose tissue (VAT) and metabolic inflammation are consequences of obesity and associated with type 2 diabetes (T2DM). Metabolically activated adipose tissue macrophages (ATMs) undergo qualitative and quantitative changes that influence their inflammatory responses. How these cells contribute to insulin resistance (IR) in humans is not well understood. Cholesterol 25-Hydroxylase (CH25H) converts cholesterol into 25-Hydroxycholesterol (25-HC), an oxysterol that modulates immune responses. Using human and murine models, we investigated the role of CH25H in metabolic inflammation.
We performed transcriptomic (RNASeq) analysis on the human whole AT biopsies and sorted ATMs from obese non-diabetic (NDM) and obese diabetic (DM) subjects to inquire if CH25H was increased in DM. We challenged mice lacking Ch25h with a high-fat diet (HFD) to characterize their metabolic and immunologic profiling. Ch25h KO mice and human adipose tissue biopsies from NDM and DM subjects were analyzed. LC-MS was conducted to measure 25-HC level in AT. In vitro analysis permitted us to investigate the effect of 25-HC on cytokine expression.
In our RNASeq analysis of human visceral and subcutaneous biopsies, gene pathways related to inflammation were increased in obese DM vs. non-DM subjects that included CH25H. CH25H was enriched in the stromal vascular fraction of human adipose tissue and highly expressed in CD206 human ATMs by flow cytometry analysis. We measured the levels of the oxysterols, 25-HC and 7α25diHC, in human visceral adipose tissue samples and showed a correlation between BMI and 25-HC. Using mouse models of diet-induced obesity (DIO), we found that HFD-induced Ch25h expression in eWAT and increased levels of 25-HC in AT. On HFD, Ch25h KO mice became obese but exhibited reduced plasma insulin levels, improved insulin action, and decreased ectopic lipid deposit. Improved insulin sensitivity in Ch25h KO mice was due to attenuation of CD11c adipose tissue macrophage infiltration in eWAT. Finally, by testing AT explants, bone marrow-derived macrophages (BMDMs) and SVF cells from Ch25h deficient mice, we observed that 25-HC is required for the expression of pro-inflammatory genes. 25-HC was also able to induce inflammatory genes in preadipocytes.
Our data suggest a critical role for CH25H/25-HC in the progression of meta-inflammation and insulin resistance in obese humans and mouse models of obesity. In response to obesogenic stimuli, CH25H/25-HC could exert a pro-inflammatory role.
内脏脂肪组织(VAT)的扩张和代谢炎症是肥胖的后果,与 2 型糖尿病(T2DM)有关。代谢激活的脂肪组织巨噬细胞(ATMs)发生定性和定量变化,影响其炎症反应。这些细胞如何导致人类胰岛素抵抗(IR)尚不清楚。胆固醇 25-羟化酶(CH25H)将胆固醇转化为 25-羟胆固醇(25-HC),一种调节免疫反应的氧化固醇。使用人类和鼠模型,我们研究了 CH25H 在代谢炎症中的作用。
我们对人类全 AT 活检进行了转录组(RNASeq)分析,并从肥胖非糖尿病(NDM)和肥胖糖尿病(DM)患者中分离出 ATMs,以询问 CH25H 是否在 DM 中增加。我们用高脂肪饮食(HFD)对缺乏 Ch25h 的小鼠进行了挑战,以描述它们的代谢和免疫特征。分析 Ch25h KO 小鼠和来自 NDM 和 DM 患者的人类脂肪组织活检。LC-MS 用于测量 AT 中的 25-HC 水平。体外分析使我们能够研究 25-HC 对细胞因子表达的影响。
在我们对人类内脏和皮下活检的 RNASeq 分析中,与非 DM 患者相比,与肥胖相关的炎症相关基因途径在肥胖 DM 患者中增加,其中包括 CH25H。CH25H 在人类脂肪组织的基质血管部分富集,并通过流式细胞术分析高度表达于 CD206 人类 ATMs。我们测量了人类内脏脂肪组织样本中氧化固醇 25-HC 和 7α25diHC 的水平,并显示 BMI 与 25-HC 之间存在相关性。使用饮食诱导肥胖(DIO)的小鼠模型,我们发现 HFD 诱导 eWAT 中的 Ch25h 表达,并增加 AT 中的 25-HC 水平。在 HFD 下,Ch25h KO 小鼠肥胖,但血浆胰岛素水平降低,胰岛素作用改善,异位脂质沉积减少。Ch25h KO 小鼠的胰岛素敏感性改善归因于 eWAT 中 CD11c 脂肪组织巨噬细胞浸润的减弱。最后,通过测试 Ch25h 缺陷小鼠的 AT 外植体、骨髓来源的巨噬细胞(BMDMs)和 SVF 细胞,我们观察到 25-HC 是表达促炎基因所必需的。25-HC 还能够诱导前脂肪细胞中的炎症基因。
我们的数据表明,CH25H/25-HC 在肥胖人群和肥胖小鼠模型的代谢炎症和胰岛素抵抗进展中起着关键作用。在肥胖刺激物的作用下,CH25H/25-HC 可能发挥促炎作用。